Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.3157.1023/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023 |
Version | 20200716 |
Status | active |
Date | 2020-07-16T01:00:25-04:00 |
Name | LiverLesionMassOrNeoplasm |
Title | Liver Lesion (Mass or Neoplasm) |
Experimental | False |
Realm | us |
Authority | hl7 |
Description | This value set is used to calculate OP-10 (Abdomen Computed Tomography (CT)—Use of Contrast Material), a claims-based measure used in the Centers for Medicare & Medicaid Services' Hospital Outpatient Quality Reporting (HOQR) Program. In calculation of OP-10, diagnoses of liver lesion (mass or neoplasm) must appear on the abdomen CT claim to be excluded from the measure’s initial patient population. |
Purpose | (Clinical Focus: This set of values contains ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Data Element Scope: The intent of the data is to identify patients with a secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Inclusion Criteria: ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct are included in this value set.),(Exclusion Criteria: Primary malignant neoplasms of the liver and intrahepatic bile duct and malignant neoplasms that are not associated with the liver, or those captured in systems other than ICD-10, are excluded from the value set.) |
No resources found
CodeSystem | |
http://hl7.org/fhir/sid/icd-10-cm ![]() | International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) |
http://hl7.org/fhir/sid/icd-10-cm ![]() | International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.3157.1023",
"meta" : {
"versionId" : "10",
"lastUpdated" : "2024-12-02T15:58:57.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Acumen OP Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-04-22"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2020-07-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.3157.1023"
}
],
"version" : "20200716",
"name" : "LiverLesionMassOrNeoplasm",
"title" : "Liver Lesion (Mass or Neoplasm)",
"status" : "active",
"experimental" : false,
"date" : "2020-07-16T01:00:25-04:00",
"publisher" : "Acumen OP Steward",
"description" : "This value set is used to calculate OP-10 (Abdomen Computed Tomography (CT)âUse of Contrast Material), a claims-based measure used in the Centers for Medicare & Medicaid Services' Hospital Outpatient Quality Reporting (HOQR) Program. In calculation of OP-10, diagnoses of liver lesion (mass or neoplasm) must appear on the abdomen CT claim to be excluded from the measureâs initial patient population.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This set of values contains ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Data Element Scope: The intent of the data is to identify patients with a secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Inclusion Criteria: ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct are included in this value set.),(Exclusion Criteria: Primary malignant neoplasms of the liver and intrahepatic bile duct and malignant neoplasms that are not associated with the liver, or those captured in systems other than ICD-10, are excluded from the value set.)",
"compose" : {
"include" : [
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"concept" : [
{
"code" : "C22.0",
"display" : "Liver cell carcinoma"
},
{
"code" : "C22.1",
"display" : "Intrahepatic bile duct carcinoma"
},
{
"code" : "C22.2",
"display" : "Hepatoblastoma"
},
{
"code" : "C22.3",
"display" : "Angiosarcoma of liver"
},
{
"code" : "C22.4",
"display" : "Other sarcomas of liver"
},
{
"code" : "C22.7",
"display" : "Other specified carcinomas of liver"
},
{
"code" : "C22.8",
"display" : "Malignant neoplasm of liver, primary, unspecified as to type"
},
{
"code" : "C22.9",
"display" : "Malignant neoplasm of liver, not specified as primary or secondary"
},
{
"code" : "C78.7",
"display" : "Secondary malignant neoplasm of liver and intrahepatic bile duct"
},
{
"code" : "C7B.02",
"display" : "Secondary carcinoid tumors of liver"
},
{
"code" : "D01.5",
"display" : "Carcinoma in situ of liver, gallbladder and bile ducts"
},
{
"code" : "D13.4",
"display" : "Benign neoplasm of liver"
},
{
"code" : "D13.5",
"display" : "Benign neoplasm of extrahepatic bile ducts"
},
{
"code" : "D37.6",
"display" : "Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:febac24a-213b-4219-94ff-3420233a0e30",
"timestamp" : "2024-12-10T10:15:12-05:00",
"total" : 14,
"contains" : [
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.0",
"display" : "Liver cell carcinoma"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.1",
"display" : "Intrahepatic bile duct carcinoma"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.2",
"display" : "Hepatoblastoma"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.3",
"display" : "Angiosarcoma of liver"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.4",
"display" : "Other sarcomas of liver"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.7",
"display" : "Other specified carcinomas of liver"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.8",
"display" : "Malignant neoplasm of liver, primary, unspecified as to type"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C22.9",
"display" : "Malignant neoplasm of liver, not specified as primary or secondary"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C78.7",
"display" : "Secondary malignant neoplasm of liver and intrahepatic bile duct"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "C7B.02",
"display" : "Secondary carcinoid tumors of liver"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "D01.5",
"display" : "Carcinoma in situ of liver, gallbladder and bile ducts"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "D13.4",
"display" : "Benign neoplasm of liver"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "D13.5",
"display" : "Benign neoplasm of extrahepatic bile ducts"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"version" : "2025",
"code" : "D37.6",
"display" : "Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.